company background image
RMDA logo

Tenth of Ramadan for Pharmaceutical Industries and Diagnostic Reagents (Rameda)E CASE:RMDA Stock Report

Last Price

ج.م2.90

Market Cap

ج.م4.3b

7D

-3.7%

1Y

84.0%

Updated

29 Feb, 2024

Data

Company Financials +

Tenth of Ramadan for Pharmaceutical Industries and Diagnostic Reagents (Rameda) S.A.E.

CASE:RMDA Stock Report

Market Cap: ج.م4.3b

RMDA Stock Overview

Tenth of Ramadan for Pharmaceutical Industries and Diagnostic Reagents (Rameda) S.A.E., together with its subsidiaries, produces and sells a range of branded generic pharmaceuticals and nutraceuticals in Egypt.

RMDA fundamental analysis
Snowflake Score
Valuation0/6
Future Growth5/6
Past Performance1/6
Financial Health4/6
Dividends0/6

Tenth of Ramadan for Pharmaceutical Industries and Diagnostic Reagents (Rameda) S.A.E. Competitors

Price History & Performance

Summary of all time highs, changes and price drops for Tenth of Ramadan for Pharmaceutical Industries and Diagnostic Reagents (Rameda)E
Historical stock prices
Current Share Priceج.م2.90
52 Week Highج.م3.40
52 Week Lowج.م1.25
Beta0.085
1 Month Change33.58%
3 Month Change73.45%
1 Year Change83.97%
3 Year Change83.54%
5 Year Changen/a
Change since IPO29.38%

Recent News & Updates

Recent updates

Shareholder Returns

RMDAEG PharmaceuticalsEG Market
7D-3.7%-2.9%-5.1%
1Y84.0%48.1%77.1%

Return vs Industry: RMDA exceeded the EG Pharmaceuticals industry which returned 48.1% over the past year.

Return vs Market: RMDA exceeded the EG Market which returned 77.1% over the past year.

Price Volatility

Is RMDA's price volatile compared to industry and market?
RMDA volatility
RMDA Average Weekly Movement11.2%
Pharmaceuticals Industry Average Movement5.9%
Market Average Movement8.3%
10% most volatile stocks in EG Market12.1%
10% least volatile stocks in EG Market5.1%

Stable Share Price: RMDA's share price has been volatile over the past 3 months.

Volatility Over Time: RMDA's weekly volatility (11%) has been stable over the past year, but is still higher than 75% of EG stocks.

About the Company

FoundedEmployeesCEOWebsite
1986n/aAmr Morsyhttps://www.ramedapharma.com

Tenth of Ramadan for Pharmaceutical Industries and Diagnostic Reagents (Rameda) S.A.E., together with its subsidiaries, produces and sells a range of branded generic pharmaceuticals and nutraceuticals in Egypt. It manufactures, markets, sells, and stores pharmaceutical reagents for human and veterinary use; and diagnostic reagents for individuals, laboratories, and hospitals. The company offers a portfolio of products in various therapeutic areas, such as anti-infective, anti-diabetic, respiratory, ophthalmology, gastrointestinal tract, cardiovascular, central nervous system, vitamins, and analgesics.

Tenth of Ramadan for Pharmaceutical Industries and Diagnostic Reagents (Rameda) S.A.E. Fundamentals Summary

How do Tenth of Ramadan for Pharmaceutical Industries and Diagnostic Reagents (Rameda)E's earnings and revenue compare to its market cap?
RMDA fundamental statistics
Market capج.م4.32b
Earnings (TTM)ج.م226.14m
Revenue (TTM)ج.م1.78b

19.1x

P/E Ratio

2.4x

P/S Ratio

Earnings & Revenue

Key profitability statistics from the latest earnings report (TTM)
RMDA income statement (TTM)
Revenueج.م1.78b
Cost of Revenueج.م948.12m
Gross Profitج.م830.94m
Other Expensesج.م604.80m
Earningsج.م226.14m

Last Reported Earnings

Sep 30, 2023

Next Earnings Date

n/a

Earnings per share (EPS)0.15
Gross Margin46.71%
Net Profit Margin12.71%
Debt/Equity Ratio66.0%

How did RMDA perform over the long term?

See historical performance and comparison
Simply Wall Street Pty Ltd (ACN 600 056 611), is a Corporate Authorised Representative (Authorised Representative Number: 467183) of Sanlam Private Wealth Pty Ltd (AFSL No. 337927). Any advice contained in this website is general advice only and has been prepared without considering your objectives, financial situation or needs. You should not rely on any advice and/or information contained in this website and before making any investment decision we recommend that you consider whether it is appropriate for your situation and seek appropriate financial, taxation and legal advice. Please read our Financial Services Guide before deciding whether to obtain financial services from us.